en

PRODUCT DETAIL

Lynparza 50 mg tvrdé kapsuly

Code 2595B
MA number EU/1/14/959/001
Product Form: cps dur 448 (4x112)x50 mg (fľ.HDPE)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors
L01XK01 Olaparib
Shelf life: 24
Container: bottle HDPE
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 16.12.2014
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 19.11.2021
eu-flag.png sk-flag.png